Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
On May 16, Pfizer (NYSE: PFE) announced that it was going to take out $31 billion in fresh debt to pay for its purchase of Seagen (NASDAQ: SGEN), an oncology drug developer. In total, it'll pay $43 billion for the company in a transaction that's set to reshape its future, and power shareholder returns for the remainder of the 2020s and perhaps beyond.
Somewhat counterintuitively, investors should interpret this debt issuance as good news for Pfizer's stock. Here's why.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Aktie
25,77 €
0,14 %
Die Pfizer Inc. Aktie steht gut da: Deutlich mehr Buy- als Sell-Einschätzungen in der Community.
Das Kursziel von 41 € für Pfizer Inc. impliziert eine deutliche Steigerung um über 50% gegenüber 25.77 €.
